These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31152846)

  • 1. The cystine/glutamate antiporter xCT is a key regulator of EphA2 S897 phosphorylation under glucose-limited conditions.
    Teramoto K; Katoh H
    Cell Signal; 2019 Oct; 62():109329. PubMed ID: 31152846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosine kinase activity of EphA2 promotes its S897 phosphorylation and glioblastoma cell proliferation.
    Hamaoka Y; Negishi M; Katoh H
    Biochem Biophys Res Commun; 2018 May; 499(4):920-926. PubMed ID: 29626472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EphA2 is a key effector of the MEK/ERK/RSK pathway regulating glioblastoma cell proliferation.
    Hamaoka Y; Negishi M; Katoh H
    Cell Signal; 2016 Aug; 28(8):937-45. PubMed ID: 27132626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High cell density increases glioblastoma cell viability under glucose deprivation via degradation of the cystine/glutamate transporter xCT (SLC7A11).
    Yamaguchi I; Yoshimura SH; Katoh H
    J Biol Chem; 2020 May; 295(20):6936-6945. PubMed ID: 32265299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The glutamate/cystine xCT antiporter antagonizes glutamine metabolism and reduces nutrient flexibility.
    Shin CS; Mishra P; Watrous JD; Carelli V; D'Aurelio M; Jain M; Chan DC
    Nat Commun; 2017 Apr; 8():15074. PubMed ID: 28429737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ROS Mediate xCT-Dependent Cell Death in Human Breast Cancer Cells under Glucose Deprivation.
    Chen MC; Hsu LL; Wang SF; Hsu CY; Lee HC; Tseng LM
    Cells; 2020 Jul; 9(7):. PubMed ID: 32630312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystine uptake through the cystine/glutamate antiporter xCT triggers glioblastoma cell death under glucose deprivation.
    Goji T; Takahara K; Negishi M; Katoh H
    J Biol Chem; 2017 Dec; 292(48):19721-19732. PubMed ID: 29038291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The glutamate/cystine antiporter SLC7A11/xCT enhances cancer cell dependency on glucose by exporting glutamate.
    Koppula P; Zhang Y; Shi J; Li W; Gan B
    J Biol Chem; 2017 Aug; 292(34):14240-14249. PubMed ID: 28630042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase C phosphorylates the EphA2 receptor on serine 892 in the regulatory linker connecting the kinase and SAM domains.
    Gehring MP; Pasquale EB
    Cell Signal; 2020 Sep; 73():109668. PubMed ID: 32413552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serine 897 Phosphorylation of EPHA2 Is Involved in Signaling of Oncogenic ERK1/2 Drivers in Thyroid Cancer Cells.
    Allocca C; Cirafici AM; Laukkanen MO; Castellone MD
    Thyroid; 2021 Jan; 31(1):76-87. PubMed ID: 32762307
    [No Abstract]   [Full Text] [Related]  

  • 11. A synthetic lethal drug combination mimics glucose deprivation-induced cancer cell death in the presence of glucose.
    Joly JH; Delfarah A; Phung PS; Parrish S; Graham NA
    J Biol Chem; 2020 Jan; 295(5):1350-1365. PubMed ID: 31914417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor promotes glioblastoma cell death under glucose deprivation via upregulation of xCT (SLC7A11).
    Yamamoto M; Teramoto K; Katoh H
    Cell Signal; 2021 Feb; 78():109874. PubMed ID: 33285240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular stress induces non-canonical activation of the receptor tyrosine kinase EphA2 through the p38-MK2-RSK signaling pathway.
    Zhou Y; Oki R; Tanaka A; Song L; Takashima A; Hamada N; Yokoyama S; Yano S; Sakurai H
    J Biol Chem; 2023 May; 299(5):104699. PubMed ID: 37059179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ionizing radiation induces EphA2 S897 phosphorylation in a MEK/ERK/RSK-dependent manner.
    Graves PR; Din SU; Ashamalla M; Ashamalla H; Gilbert TSK; Graves LM
    Int J Radiat Biol; 2017 Sep; 93(9):929-936. PubMed ID: 28705041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A negative correlation between expression profiles of runt-related transcription factor-2 and cystine/glutamate antiporter xCT subunit in ovariectomized mouse bone.
    Uno K; Takarada T; Nakamura Y; Fujita H; Hinoi E; Yoneda Y
    J Pharmacol Sci; 2011; 115(3):309-19. PubMed ID: 21325781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redox-dependent AMPK inactivation disrupts metabolic adaptation to glucose starvation in xCT-overexpressing cancer cells.
    Lee Y; Itahana Y; Ong CC; Itahana K
    J Cell Sci; 2022 Aug; 135(15):. PubMed ID: 35775474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase A can block EphA2 receptor-mediated cell repulsion by increasing EphA2 S897 phosphorylation.
    Barquilla A; Lamberto I; Noberini R; Heynen-Genel S; Brill LM; Pasquale EB
    Mol Biol Cell; 2016 Sep; 27(17):2757-70. PubMed ID: 27385333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The x(c)(-) cystine/glutamate antiporter (xCT) as a potential target for therapy of cancer: yet another cytotoxic anticancer approach?
    Savaskan NE; Hahnen E; Eyüpoglu IY
    J Cell Physiol; 2009 Aug; 220(2):531-2; author reply 533-4. PubMed ID: 19415694
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification, Expression, and Roles of the Cystine/Glutamate Antiporter in Ocular Tissues.
    Martis RM; Knight LJ; Donaldson PJ; Lim JC
    Oxid Med Cell Longev; 2020; 2020():4594606. PubMed ID: 32655769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Merlin/NF2 regulates SLC7A11/xCT expression and cell viability under glucose deprivation at high cell density in glioblastoma cells.
    Yamaguchi I; Katoh H
    J Biochem; 2024 Mar; 175(3):313-322. PubMed ID: 38102738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.